UC Davis continues its public outreach on the coronavirus and the COVID-19 pandemic with two livestreamed programs the first week of June, featuring experts from the university and around the country discussing the progress being made in testing for and vaccinating against the disease.
The first program, focusing primarily on vaccines, is scheduled for Wednesday (June 3), as the third symposium in a public awareness series organized by Distinguished Professor Walter Leal of the Department of Molecular and Cellular Biology.
Scientists from the University of California, Davis are conducting a survey to learn about the impacts of the COVID-19 (Coronavirus) outbreak that began early in 2020.
(SACRAMENTO) — COVID-19 research and clinical trials throughout UC Davis have a quiet and crucial backbone that is hard to describe – even for the directors of this center providing the support.
Computer scientists at the University of California, Davis, have developed a web-based contact-tracing application. The app, We-Care, allows users to check in at specific locations and notifies them if someone reporting themselves as positive for COVID-19 checks in at the same location within a certain time window.
With new seed grants from the UC Davis Office of Research’s COVID-19 Research Accelerator Funding Track (CRAFT), three teams of UC Davis engineers are applying their expertise toward the pandemic response to help people become safer, healthier and better-tested.
(SACRAMENTO) — Richard Levenson, professor of pathology and laboratory medicine at UC Davis Health, received a $25,000 COVID Catalyst award to evaluate the effectiveness of a variant of the compound chitosan in blocking infection by the novel coronavirus.
